Edgewood Management
AGN

Edgewood Management’s Allergan Inc AGN Stock Holding History

Edgewood Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,812,488
Closed -$385M – 84
2014
Q4 		$385M Sell
1,812,488
-887,439
-33% -$176M 3.55% 17
2014
Q3 		$481M Buy
2,699,927
+17,601
+0.7% +$2.92M 4.83% 8
2014
Q2 		$454M Sell
2,682,326
-1,256,467
-32% -$196M 4.6% 7
2014
Q1 		$489M Buy
3,938,793
+725,240
+23% +$88.3M 5.2% 6
2013
Q4 		$357M Sell
3,213,553
-18,091
-0.6% -$1.73M 3.99% 14
2013
Q3 		$292M Sell
3,231,644
-5,051
-0.2% -$453K 3.66% 17
2013
Q2 		$273M Buy
+3,236,695
New +$336M 3.67% 14

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Edgewood Management's AGN Position: Q1 2015 in Review

Edgewood Management sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 1,812,488 shares — an estimated $385M sold.

Edgewood Management first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $489M in Q1 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Edgewood Management reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Edgewood Management sold 1,812,488 Allergan Inc shares in Q1 2015, an estimated $385M.
  • Edgewood Management first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Edgewood Management's Allergan Inc position peaked at $489M in Q1 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Edgewood Management's 13F filing for Q1 2015, filed 6 May 2015.